Inhibiting PYK2 activity using the dual PYK2/FAK inhibitor PF431396 destabilizes TAZ and also inhibits YAP/TAZ activity in triple negative breast cancer cells 87. The gene discussed is PTK2B; the disease is triple-negative breast carcinoma.